VICTORION-2 PREVENT (Follow-up)
A randomized double-blind, placebo controlled, multicenter trial, assessing the impact of Inclisiran on major adverse cardiovascular events in patients with established cardiovascular disease
- Medicine
- Inclisiran
- Population
- ASCVD
- Phase
- III
- Starting year
- 2021